Atlas Trials

Ruxolitinib to Combat COVID-19

Clinical trial NCT04354714 · WITHDRAWN

Trial details

NCT number
NCT04354714
Sponsor
Washington University School of Medicine
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19
Start date
2020-06-30
Primary completion
2021-07-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.